Pharmacokinetics of CAMPATH-1H: assay development and validation

Reshaping human antibodies for therapy

Lutz Riechmann, Herman Waldmann, Greg Winter · Nature · 1988 · 1.6K citations

Pharmacy, Immunology, Pharmaceutical Biotechnology +12

Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma

Neil L. Berinstein, A.J. Grillo-López, Christine A. White et al. · Annals of Oncology · 1998 · 523 citations · Full text

Medicine, Hematology, Oncology +15

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement

G Hale, S Bright, G Chumbley et al. · Blood · 1983 · 363 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor

Gootenberg Je, FW Ruscetti, J W Mier et al. · The Journal of Experimental Medicine · 1981 · 336 citations · Full text

Life Sciences, Cell Biology, Oncology +10

Characterization of the CAMPATH‐1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone

Meng‐Qi Xia, Masahide Tone, Len C. Packman et al. · European Journal of Immunology · 1991 · 169 citations

Life Sciences, Biochemistry, Immunology +13